Reducing pulmonary complications after esophagectomy for cancer
Review Article

Reducing pulmonary complications after esophagectomy for cancer

Maarten F. J. Seesing, B. Feike Kingma, Teus J. Weijs, Jelle P. Ruurda, Richard van Hillegersberg

Department of Surgical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands

Contributions: (I) Conception and design: All authors; (II) Administrative support: MF Seesing, BF Kingma; (III) Provision of study materials or patients: None; (IV) Collection and assembly of data: None; (V) Data analysis and interpretation: None; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.

Correspondence to: Richard van Hillegersberg, MD, PhD. Department of Surgery, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. Email: r.vanhillegersberg@umcutrecht.nl.

Abstract: The cornerstone of curative care for esophageal cancer is neoadjuvant chemoradiotherapy followed by esophagectomy with a radical lymphadenectomy. An esophagectomy is a major and complex surgical procedure and is often followed by postoperative morbidity, especially pulmonary complications. These complications may lead to an increase in hospital stay, intensive care unit admission rate and mortality. Therefore, perioperative strategies to reduce these complications have been investigated and implemented in clinical practice. In this review we highlight the influence of minimally invasive surgery, postoperative pain management, early identification of complications and the usage of uniform definitions on (pulmonary) complications after esophagectomy. Finally, we will discuss some future perspectives.

Keywords: Esophagectomy; surgery; postoperative morbidity; ERAS


Submitted Nov 09, 2018. Accepted for publication Nov 19, 2018.

doi: 10.21037/jtd.2018.11.75


Introduction

Esophageal cancer has a fast-growing incidence. Currently it is the eight most common cancer worldwide, with 456,000 patients diagnosed each year. Moreover, it is an aggressive disease, illustrated by the annual worldwide cancer-related mortality rate of approximately 406,800. The cornerstone of curative care for esophageal cancer is neoadjuvant chemoradiotherapy followed by esophagectomy with a two-field lymphadenectomy. Although many advances in surgical techniques have already been made, postoperative morbidity remains high, with morbidity and mortality incidences reported up to 65% and 15% respectively. Especially pulmonary complications are frequently observed after esophagectomy, leading to an increased hospital- and intensive care unit stay. In this paper we review the influence of minimally invasive surgery, postoperative pain management, early identification of complications and the usage of uniform definitions on (pulmonary) complications after esophagectomy. Finally, we discuss some future perspectives.


Minimally invasive surgery

Minimally invasive surgery has become the standard of care in many surgical procedures. The use of minimally invasive techniques may reduce blood loss, postoperative pain and complications. This generally leads to a shorter hospital stay and an improved quality of life. Nevertheless, the standard surgical approach for esophagectomy has always been by means of a laparotomy or a combined laparotomy and thoracotomy (1). The first thoracoscopic esophagectomy was performed in 1992 by Sir Alfred Cuschieri, a pioneer in minimally invasive surgery (2). Subsequently, the safety and feasibility of MIE were demonstrated by case series (3,4). The only randomized controlled trial comparing open and conventional minimally invasive esophagectomy published to date (TIME trial) demonstrated a shorter hospital stay, a reduction of postoperative pulmonary infections and a better short-term quality of life in favor of the minimally invasive group, without compromising radicality and lymph node yield (5). Also a hybrid approach may reduce postoperative complications after esophagectomy when compared to an open approach (6). Although several studies demonstrated comparable short-term benefits of minimally invasive esophagectomy when compared to the open approach, some population-based studies were unable to identify a difference in the pulmonary complication rate and even showed increased rates of anastomotic leakage- and reintervention in patients who underwent a minimally invasive esophagectomy (7-10). A possible explanation for these findings might be the rapid introduction and wide implementation of minimally invasive esophagectomy, which carries a significant learning curve. A multicenter retrospective study showed that the learning curve of minimally invasive esophagectomy with an intrathoracic anastomosis was over 100 cases to reach a plateau incidence of anastomotic leakage, despite the fact that all participating surgeons were already experienced in minimally invasive esophagectomy with a cervical anastomosis before transiting (11). These outcomes warrant more dedicated proctor programs and additional research to investigate how learning associated morbidity may be further reduced and preferably eliminated. The benefits of minimally invasive surgery will expectantly start to show after learning curve completion.

Within minimally invasive esophagectomy, a variety of performance shaping factors may influence postoperative outcomes. The first thoracoscopic esophagectomy was performed with the patient in left lateral decubitus position. To improve the exposure of the posterior mediastinum and obtain better ergonomic results, some surgeons suggested changing the left lateral decubitus position to a prone position. Nevertheless, conversion to open surgery may be easier in left lateral decubitus position. The semiprone position, combining “the best of both worlds”, has been proposed as an alternative and was found to be at least comparable to a prone positioning in terms of oncological quality and occurrence of postoperative complications (12). Minimally invasive esophagectomy may be further facilitated by using robotic assistance (13,14). Besides its ergonomic benefits, robotic assistance enables the surgeon to reach the upper mediastinum and thoracic aperture with more ease (15). This facilitates an extended lymphadenectomy along the recurrent laryngeal nerves, which may increase the chances of long-term disease-free survival. The recently published ROBOT trial, a randomized controlled trial comparing open esophagectomy versus robot-assisted minimally invasive esophagectomy (RAMIE), clearly demonstrates the benefits of the robotic approach (16). RAMIE was associated with less intraoperative blood loss, a lower overall postoperative complication rate, a shorter length of hospital stay, better short-term quality of life, and a faster functional recovery when compared to open esophagectomy (16). In combination with comparable lymph node yield, radicality, and survival, one can conclude that RAMIE is effective in reducing postoperative complications while maintaining high oncological standards (16). The use of RAMIE may also open new indications for curative surgery in patients with T4b tumors, high mediastinal tumors and lymph node metastases after neoadjuvant treatment (15,17).


Perioperative care

Over 50% of all patients will develop one or more complications after esophagectomy, which frequently involves pulmonary complications. To reduce the risk of developing postoperative pulmonary complications, adequate breathing and early mobilization should be facilitated. Effective postoperative pain management is essential context (18). Epidural analgesia is the current gold standard following esophageal surgery, as it was associated with better pain control, less pneumonia, and a lower mortality rate when compared to intravenous opioids in patients who underwent open transthoracic esophagectomy (19). However, due to the inherent bilateral block of sympathetic nerves, epidural analgesia can cause hypotensive events that may hamper mobilization and thereby counteract an important benefit of adequate pain control. Paravertebral analgesia has been suggested as an alternative, as it can conceptually induce a satisfactory unilateral sensory block while avoiding bilateral block of sympathetic nerves. In a Cochrane review that compared epidural versus paravertebral analgesia in patients who underwent thoracotomy procedures, pain control was comparable between these techniques and paravertebral analgesia was associated with less hypotension, nausea, urinary retention, and itch (20). Although prospective series are lacking for patients undergoing esophageal surgery, a retrospective study found that paravertebral analgesia was associated with less need for inotropic support and shorter length of stay on the intensive care unit when compared to epidural analgesia for pain control after open esophagectomy (21). The implementation of paravertebral analgesia in the context of an enhanced recovery protocol has also been described (22). As these results are promising, more research is warranted to investigate the potential merits of paravertebral block in esophageal surgery, preferably in the setting of a randomized prospective trial.

Besides pulmonary complications, other problems such as anastomotic leakage, atrial fibrillation, and chylothorax are common after esophagectomy. Once complications occur, early identification and treatment is essential to minimize the failure to rescue rate. Early recognition of complications limits the development of the systemic inflammatory response syndrome, consequently reducing the severity of encountered complications (23). Postoperative complications may have linked pathophysiology, and therefore can also function as an early warning sign. For example, atrial fibrillation is a frequently encountered complication after esophagectomy and is rarely seen in isolation. Atrial fibrillation is frequently associated with pneumonia and anastomotic leakage (24-27). This implies that, atrial fibrillation may be of predictive value and it therefore seems advisable to have a low threshold for initiation of additional diagnostic work-up in case signs of cardiac arrhythmia are observed after esophagectomy. Also, recurrent laryngeal nerve injury and pulmonary complications have a linked pathophysiology. It has been demonstrated that recurrent laryngeal nerve injury increases the chance of aspiration pneumonia and therefore requires extra attention (28,29). In addition, recurrent laryngeal nerve injury has a relatively high impact on long-term outcomes (30). Up to a quarter of all patients who suffer from recurrent laryngeal nerve paralysis after esophagectomy require vocal cord surgery within a year after esophagectomy (30). This is an extra argument to make a serious effort to minimize recurrent laryngeal nerve injury during esophagectomy.


Outcome definitions

Before 2015, no widely accepted system existed for the documentation of complications that are associated with esophagectomy. As a result, widely varying definitions for complications were used, making comparisons between studies difficult (31). Although the publication by Low et al., in which the most frequently encountered postoperative complications were standardized, has been a major step in developing standardized and uniformly used definitions for complications after esophagectomy for cancer, it still does not cover all definitions (32). An uniform definition for post esophagectomy pneumonia, which is highly frequent observed, is lacking. The Uniform Pneumonia Score fills this gap (33). The Uniform Pneumonia Score is the only objective to precisely define pneumonia after esophagectomy and was validated in Europe and North-America (34,35). Taking this into account, it remains questionable whether the Uniform Pneumonia Score will also function in an Asian population. Patients in Western society are usually older and have a different set of comorbidities, such as those associated with obesity (36). Furthermore, squamous cell carcinoma is more frequent in Asia and patients more often present with early stage cancer as a result of active screening programs (36,37). This affects decision making regarding neoadjuvant regimens, which consequently affects the postoperative course. Next to tumor- and patient related factors, the health care system and the clinical decision making in Asian society is different from western society. Validation of the Uniform Pneumonia Score in an Asian population would therefore be most valuable and should preferably be carried out by independent researchers. However, despite lacking validation studies for Asian populations, the Uniform Pneumonia Score is the best available definition for pneumonia after esophagectomy that has been published to date and is therefore strongly recommended for use in future research.


Conclusions and future perspectives

Several important aspects of perioperative care in esophageal cancer surgery are addressed in this review. As already pointed out above, it would be valuable to validate the Uniform Pneumonia Score in an Asian population. If the Uniform Pneumonia Score is indeed also valid in Asian populations and will be used as a standard definition in research worldwide, this may reveal the true effectiveness of intra- and perioperative strategies to reduce pneumonia after esophagectomy by allowing fair comparison of literature.

The next step for minimally invasive esophagectomy will be its further implementation and centralization. The outcomes of minimally invasive esophagectomy may be improved by centralization of esophageal cancer care (38). One may compare surgery to sports: extended experience and practice will lead to better results. This applies not only to the surgeon, but to all health care professionals involved in the esophageal cancer care chain. In order to achieve safe implementation of minimally invasive esophagectomy it is pivotal to follow strict guidelines and proctor programs (39). At the same time, further improvement of minimally invasive esophagectomy may be achieved with robotic assistance. Although robotic assistance may improve outcomes for both the surgeon (ergonomics) and the patient, costs are currently high. Not many companies produce surgical robots at this moment, which hinders healthy forces of supply and demand. More competition on this marked will decrease costs and facilitate the further implementation and development of robotic surgery. In terms of future developments in robotic surgery, one could think of augmented reality. Augmented reality allows you to still keep in touch with the real world, while at the same time adding an extra layer. This technique can be used to construct a virtual image, like a CT-scan or MRI that may overlap a real-time camera feed. For example, this may enable the surgeon to visualize the location and extent of a tumor in relationship to its surrounding structures. In addition, the creation of a three-dimensional panorama by the stereoscopic camera is expected in new robotic surgical system, which can enhance the surgeon’s view of the surgical field.


Acknowledgements

None.


Footnote

Conflicts of Interest: The authors have no conflicts of interest to declare.


References

  1. Haverkamp L, Seesing MF, Ruurda JP, et al. Worldwide trends in surgical techniques in the treatment of esophageal and gastroesophageal junction cancer. Dis Esophagus 2017;30:1-7. [PubMed]
  2. Cuschieri A, Shimi S, Banting S. Endoscopic oesophagectomy through a right thoracoscopic approach. J R Coll Surg Edinb 1992;37:7-11. [PubMed]
  3. Luketich JD, Alvelo-Rivera M, Buenaventura PO, et al. Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg 2003;238:486-94; discussion 494-5. [PubMed]
  4. Luketich JD, Pennathur A, Franchetti Y, et al. Minimally invasive esophagectomy: results of a prospective phase II multicenter trial-the eastern cooperative oncology group (E2202) study. Ann Surg 2015;261:702-7. [Crossref] [PubMed]
  5. Biere SS, van Berge Henegouwen MI, Maas KW, et al. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet 2012;379:1887-92. [Crossref] [PubMed]
  6. Briez N, Piessen G, Bonnetain F, et al. Open versus laparoscopically-assisted oesophagectomy for cancer: a multicentre randomised controlled phase III trial - the MIRO trial. BMC Cancer 2011;11:310. [Crossref] [PubMed]
  7. Takeuchi H, Miyata H, Ozawa S, et al. Comparison of Short-Term Outcomes Between Open and Minimally Invasive Esophagectomy for Esophageal Cancer Using a Nationwide Database in Japan. Ann Surg Oncol 2017;24:1821-7. [Crossref] [PubMed]
  8. Seesing MFJ, Gisbertz SS, Goense L, et al. A Propensity Score Matched Analysis of Open Versus Minimally Invasive Transthoracic Esophagectomy in the Netherlands. Ann Surg 2017;266:839-46. [Crossref] [PubMed]
  9. Mamidanna R, Bottle A, Aylin P, et al. Short-term outcomes following open versus minimally invasive esophagectomy for cancer in England: a population-based national study. Ann Surg 2012;255:197-203. [Crossref] [PubMed]
  10. Sihag S, Kosinski AS, Gaissert HA, et al. Minimally Invasive Versus Open Esophagectomy for Esophageal Cancer: A Comparison of Early Surgical Outcomes From The Society of Thoracic Surgeons National Database. Ann Thorac Surg 2016;101:1281-8; discussion 1288-9. [Crossref] [PubMed]
  11. van Workum F, Stenstra MHBC, Berkelmans GHK, et al. Learning Curve and Associated Morbidity of Minimally Invasive Esophagectomy: A Retrospective Multicenter Study. Ann Surg 2019;269:88-94. [Crossref] [PubMed]
  12. Seesing MFJ, Goense L, Ruurda JP, et al. Minimally invasive esophagectomy: a propensity score-matched analysis of semiprone versus prone position. Surg Endosc 2018;32:2758-65. [Crossref] [PubMed]
  13. van Hillegersberg R, Boone J, Draaisma WA, et al. First experience with robot-assisted thoracoscopic esophagolymphadenectomy for esophageal cancer. Surg Endosc 2006;20:1435-9. [Crossref] [PubMed]
  14. Ruurda JP, van der Sluis PC, van der Horst S, et al. Robot-assisted minimally invasive esophagectomy for esophageal cancer: A systematic review. J Surg Oncol 2015;112:257-65. [Crossref] [PubMed]
  15. van der Horst S, Weijs TJ, Ruurda JP, et al. Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy for esophageal cancer in the upper mediastinum. J Thorac Dis 2017;9:S834-42. [Crossref] [PubMed]
  16. van der Sluis PC, van der Horst S, May AM, et al. Robot-assisted Minimally Invasive Thoracolaparoscopic Esophagectomy Versus Open Transthoracic Esophagectomy for Resectable Esophageal Cancer: A Randomized Controlled Trial. Ann Surg 2019;269:621-30. [Crossref] [PubMed]
  17. van Hillegersberg R, Seesing MF, Brenkman HJ, et al. Robot-assisted minimally invasive esophagectomy. Chirurg 2017;88:7-11. [Crossref] [PubMed]
  18. Richardson J, Sabanathan S, Mearns AJ, et al. Efficacy of pre-emptive analgesia and continuous extrapleural intercostal nerve block on post-thoracotomy pain and pulmonary mechanics. J Cardiovasc Surg (Torino) 1994;35:219-28. [PubMed]
  19. Cense HA, Lagarde SM, de Jong K, et al. Association of no epidural analgesia with postoperative morbidity and mortality after transthoracic esophageal cancer resection. J Am Coll Surg 2006;202:395-400. [Crossref] [PubMed]
  20. Yeung JH, Gates S, Naidu BV, et al. Paravertebral block versus thoracic epidural for patients undergoing thoracotomy. Cochrane Database Syst Rev 2016;2:CD009121. [PubMed]
  21. Phillips S, Dedic-Hagan J, Baxter DF, et al. A Novel Technique of Paravertebral Thoracic and Preperitoneal Analgesia Enhances Early Recovery After Oesophagectomy. World J Surg 2018;42:1787-91. [Crossref] [PubMed]
  22. Cheong E. How minimally invasive esophagectomy was implemented at the Norfolk and Norwich University Hospital. J Thorac Dis 2017;9:S879-85. [Crossref] [PubMed]
  23. Paul S, Bueno R. Section VI: complications following esophagectomy: early detection, treatment, and prevention. Semin Thorac Cardiovasc Surg 2003;15:210-5. [Crossref] [PubMed]
  24. Murthy SC, Law S, Whooley BP, et al. Atrial fibrillation after esophagectomy is a marker for postoperative morbidity and mortality. J Thorac Cardiovasc Surg 2003;126:1162-7. [Crossref] [PubMed]
  25. Stawicki SP, Prosciak MP, Gerlach AT, et al. Atrial fibrillation after esophagectomy: an indicator of postoperative morbidity. Gen Thorac Cardiovasc Surg 2011;59:399-405. [Crossref] [PubMed]
  26. Mc Cormack O, Zaborowski A, King S, et al. New-onset atrial fibrillation post-surgery for esophageal and junctional cancer: incidence, management, and impact on short- and long-term outcomes. Ann Surg 2014;260:772-8; discussion 778. [Crossref] [PubMed]
  27. Stippel DL, Taylan C, Schroder W, et al. Supraventricular tachyarrhythmia as early indicator of a complicated course after esophagectomy. Dis Esophagus 2005;18:267-73. [Crossref] [PubMed]
  28. Koyanagi K, Igaki H, Iwabu J, et al. Recurrent Laryngeal Nerve Paralysis after Esophagectomy: Respiratory Complications and Role of Nerve Reconstruction. Tohoku J Exp Med 2015;237:1-8. [Crossref] [PubMed]
  29. Gockel I, Kneist W, Keilmann A, et al. Recurrent laryngeal nerve paralysis (RLNP) following esophagectomy for carcinoma. Eur J Surg Oncol 2005;31:277-81. [Crossref] [PubMed]
  30. Scholtemeijer MG, Seesing MFJ, Brenkman HJF, et al. Recurrent laryngeal nerve injury after esophagectomy for esophageal cancer: incidence, management, and impact on short- and long-term outcomes. J Thorac Dis 2017;9:S868-78. [Crossref] [PubMed]
  31. Blencowe NS, Strong S, McNair AG, et al. Reporting of short-term clinical outcomes after esophagectomy: a systematic review. Ann Surg 2012;255:658-66. [Crossref] [PubMed]
  32. Low DE, Alderson D, Cecconello I, et al. International Consensus on Standardization of Data Collection for Complications Associated With Esophagectomy: Esophagectomy Complications Consensus Group (ECCG). Ann Surg 2015;262:286-94. [Crossref] [PubMed]
  33. van der Sluis PC, Verhage RJ, van der Horst S, et al. A new clinical scoring system to define pneumonia following esophagectomy for cancer. Dig Surg 2014;31:108-16. [Crossref] [PubMed]
  34. Seesing MFJ, Wirsching A, van Rossum PSN, et al. Defining pneumonia after esophagectomy for cancer: validation of the Uniform Pneumonia Score in a high volume center in North America. Dis Esophagus 2018;31. [Crossref] [PubMed]
  35. Weijs TJ, Seesing MF, van Rossum PS, et al. Internal and External Validation of a multivariable Model to Define Hospital-Acquired Pneumonia After Esophagectomy. J Gastrointest Surg 2016;20:680-7. [Crossref] [PubMed]
  36. Zhang Y, Xiang J, Han Y, et al. Initial experience of robot-assisted Ivor-Lewis esophagectomy: 61 consecutive cases from a single Chinese institution. Dis Esophagus 2018. [Epub ahead of print]. [Crossref] [PubMed]
  37. Kim JA, Shah PM. Screening and prevention strategies and endoscopic management of early esophageal cancer. Chin Clin Oncol 2017;6:50. [Crossref] [PubMed]
  38. Henneman D, Dikken JL, Putter H, et al. Centralization of esophagectomy: how far should we go? Ann Surg Oncol 2014;21:4068-74. [Crossref] [PubMed]
  39. van der Sluis PC, Ruurda JP, van der Horst S, et al. Learning Curve for Robot-Assisted Minimally Invasive Thoracoscopic Esophagectomy: Results From 312 Cases. Ann Thorac Surg 2018;106:264-71. [Crossref] [PubMed]
Cite this article as: Seesing MF, Kingma BF, Weijs TJ, Ruurda JP, van Hillegersberg R. Reducing pulmonary complications after esophagectomy for cancer. J Thorac Dis 2019;11(Suppl 5):S794-S798. doi: 10.21037/jtd.2018.11.75